Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-o-tetrahydropyranyladriamycin
2. 4'-o-tetrahydropyranyldoxorubicin
3. 4'-o-tetrapyranyldoxorubicin
4. Pirarubicin
5. Pirarubicin Hydrochloride
6. Thprubicine
7. Thepirubicin
8. Theprubicin
9. Therarubicin
10. Thp-adm
11. Thp-adriamycin
12. Thp-dox
13. Thp-doxorubicin
1. Therarubicin (tn)
2. Pirarubicin Hydrochloride
3. Pinorubin (tn)
4. Dtxsid00915024
5. D08386
6. (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-6-methyl-5-[(2s)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride
7. 3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-o-oxan-2-ylhexopyranoside--hydrogen Chloride (1/1)
| Molecular Weight | 664.1 g/mol |
|---|---|
| Molecular Formula | C32H38ClNO12 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 7 |
| Exact Mass | 663.2082533 g/mol |
| Monoisotopic Mass | 663.2082533 g/mol |
| Topological Polar Surface Area | 204 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 1120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
A Pirarubicin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pirarubicin HCl, including repackagers and relabelers. The FDA regulates Pirarubicin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pirarubicin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pirarubicin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pirarubicin HCl supplier is an individual or a company that provides Pirarubicin HCl active pharmaceutical ingredient (API) or Pirarubicin HCl finished formulations upon request. The Pirarubicin HCl suppliers may include Pirarubicin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Pirarubicin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pirarubicin HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Pirarubicin HCl active pharmaceutical ingredient (API) in detail. Different forms of Pirarubicin HCl DMFs exist exist since differing nations have different regulations, such as Pirarubicin HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pirarubicin HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Pirarubicin HCl USDMF includes data on Pirarubicin HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pirarubicin HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pirarubicin HCl suppliers with USDMF on PharmaCompass.
Pirarubicin HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pirarubicin HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pirarubicin HCl GMP manufacturer or Pirarubicin HCl GMP API supplier for your needs.
A Pirarubicin HCl CoA (Certificate of Analysis) is a formal document that attests to Pirarubicin HCl's compliance with Pirarubicin HCl specifications and serves as a tool for batch-level quality control.
Pirarubicin HCl CoA mostly includes findings from lab analyses of a specific batch. For each Pirarubicin HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pirarubicin HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Pirarubicin HCl EP), Pirarubicin HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pirarubicin HCl USP).
LOOKING FOR A SUPPLIER?
